Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.34
-0.29-3.74%
Last update: Oct 8, 4:00 PM
$7.30
-0.33-4.33%
Satellos Bioscience Inc (MSLE) Stock Price, Quote, News & History
MSLENASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Satellos Bioscience (NASDAQ:MSLE) through any online brokerage.
Other companies in Satellos Bioscience’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Satellos Bioscience has a consensus price target of $21.25.
The stock price for Satellos Bioscience (NASDAQ: MSLE) is $7.3 last updated October 8, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Satellos Bioscience.
Satellos Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Satellos Bioscience.
Satellos Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
